Avanos Medical Reaches Analyst Target Price
October 07, 2020 at 07:44 AM EDT
In recent trading, shares of Avanos Medical Inc (AVNS) have crossed above the average analyst 12-month target price of $36.00, changing hands for $36.61/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..